Leucid Bio
Signal active
Organization
Contact Information
Overview
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part of Leucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.
About
Industries
Biotechnology, Health Care
Founded
2014
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Leucid Bio headquartered in Europe, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $126.9M in funding across 8 round(s). With a team of 11-50 employees, Leucid Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Leucid Bio, raised $15.9M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
5
Lead Investors
0
Total Funding Amount
$15.9M
Details
1
Leucid Bio has raised a total of $15.9M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 15.9M |
Investors
Leucid Bio is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Graziano Seghezzi | - | FUNDING ROUND - Graziano Seghezzi | 15.9M |
| Sofinnova Partners | - | FUNDING ROUND - Sofinnova Partners | 15.9M |
| Leucid Bio | - | FUNDING ROUND - Leucid Bio | 15.9M |
| 2invest | - | FUNDING ROUND - 2invest | 15.9M |
Recent Activity
There is no recent news or activity for this profile.